The Jinshan Hospital affiliated to Fudan University Long non-coding RNAs (lncRNAs) have been validated to play important role in multiple cancers, including non-small cell lung cancer (NSCLC). In present study, our team investigate the biologic role of SNHG15 in the NSCLC tumorigenesis. LncRNA SNHG15 was significantly upregulated in NSCLC tissue samples and cells, and its overexpression was associated with poor prognosis of NSCLC patients. In vitro, lossof-functional cellular experiments showed that SNHG15 silencing significantly inhibited the proliferation, promoted the apoptosis, and induced the cycle arrest at G0//G1 phase. In vivo, xenograft assay showed that SNHG15 silencing suppressed tumor growth of NSCLC cells. Besides, SNHG15 silencing decreased CDK14 protein expression both in vivo and vitro. Bioinformatics tools and luciferase reporter assay confirmed that miR-486 both targeted the 3′-UTR of SNHG15 and CDK14 and was negatively correlated with their expression levels. In summary, our study conclude that the ectopic overexpression of SNHG15 contribute to the NSCLC tumorigenesis by regulating CDK14 protein via sponging miR-486, providing a novel insight for NSCLC pathogenesis and potential therapeutic strategy for NSCLC patients.
verified that lncRNAs function as important regulators in multiple molecular regulation, involving transcription and post-transcription regulation, and modification (Alvarez-Dominguez & Lodish, 2017; Marchese, Raimondi, & Huarte, 2017) . For example, lncRNA GAS5 was downregulated in NSCLC tissues and cells and was negatively correlated with miR-23a expression to alleviate the NSCLC tumorigenesis (Mei et al., 2017) . For another example, lncRNA MIAT is upregulated in NSCLC and the overexpression was associated with advanced tumor stage, promoting non-small cell lung cancer proliferation and metastasis through MMP9 activation (Lai et al., 2017) .
LncRNA SNHG15 has been reported as a oncogenic gene in tumors to aggravate carcinogenesis through epigenetic regulation (Ma, Xue et al., 2017; Ma, Huang et al., 2017) . For example, SNHG15 promotes breast cancer proliferation, migration, and invasion by sponging miR-211-3p (Kong & Qiu, 2018) . In osteosarcoma cells, SNHG15 contributes to proliferation, invasion, and autophagy by sponging miR-141 (Liu, Hou, Liu, & Zheng, 2017) . In the present study, our team investigated the potential roles of lncRNA SNHG15 in the tumorigenesis and progression of NSCLC.
Results revealed that SNHG15 was up-regulated in NSCLC tissue and cells and accelerated the NSCLC proliferation and progression through promoting CDK14 via miR-486. Our results illuminate a novel molecular mechanism and provide an effective treatment strategy for NSCLC. 
| MATERIALS AND METHODS

| Tissue samples
| Cell lines and culture
The NSCLC cell lines (A549, H460, SK-MES-1, and Calu-3) were purchased from the American Type Culture Collection (ATCC, Manassas, VA) and cultured in Dulbecco's Modified Eagle's medium (DMEM, Invitrogen, Carlsbad, CA). The normal human bronchial epithelial cells (NHBE) and HEK-293T cells were purchased from the Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China) and cultured in RPMI-1640 medium (Gibco, Waltham, MA) supplemented with 10% FBS (Gibco), 100 U/ml penicillin and 100 µg/ml streptomycin. Cells were cultured in DMEM medium (Invitrogen). All cells were cultured in a 5% CO 2 humidified atmosphere at 37°C.
| Transfection
All these interfering RNAs and sequences were chemically synthesized by GenePharma (Shanghai, China), including siRNA against SNHG15 (si-SNHG15), short-hairpin RNA plasmid directly targeting SNHG15 (shSNHG15), miR-486 inhibitor, control miRNA (miR-NC). Oligonucleotide transfection into NSCLC cells were performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. After transfection of 48 hr, the cells were collected for further experiment.
| RNA extraction and quantitative real-time polymerase chain reaction (qRT-PCR)
Total RNA was extracted from NSCLC tissues and cells using TRIzol reagent (TaKaRa, Dalian, China) . The concentration and purity of RNA were measured at 260/280 nm using NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA). The reverse transcription (RT) reactions were performed using a Prime Script™ RT Reagent Kit (Takara). The specific primers used for RT-PCR were as following: SNHG15, 5′-TTGTGAAGCCCAGTGAAAGTACTGC-3′ (forward), 5′-TTCACTGTGGAGACTGTCGTTGGT-3′ (reverse); miR-486, 5′-GTGAGTGGAACAATGTGTGG-3′ (forward), 5′-AAAGCAAAC-GATGCCAAGAC-3′ (reverse); GAPDH, 5′-AGCCACATCGCTCA-GACA-3′ (forward), 5′-TGGACTCCACGACGTACT-3′ (reverse). The results were normalized to GAPDH to obtain the comparative cycle threshold (Ct) (2 −ΔΔCt ) values, and then converted to fold changes. 
| Proliferation ability assay
| Flow cytometry apoptosis and cycle analysis
Apoptosis and cell cycle were analyzed using flow cytometry. Briefly, A549 and H460 cells were treated with 400 µl binding buffer, 5 µl Annexin V-FITC, and 5 µl propidium iodide (PI) using Annexin V-FITC Apoptosis Detection Kit (Invitrogen). And then cells were seeded into six-well plates and the apoptosis was measured using BioVision Annexin V-FITC reagent kit (Sigma-Aldrich, Louis, MO). Finally, the apoptotic rate was measured using a Beckman-Coulter CyAN ADP Analyzer (Beckman Coulter, Inc. Kraemer Boulevard Brea, CA). For cycle analysis, A549 and H460 cells were resuspended using PBS containing 70% ethanol, Rnase A (0.5 mg/ml) and propidium iodide (0.1 mg/ml) and measured using flow cytometry.
| Western blot analysis
Total protein was lysed using Radio Immunoprecipitation Assay (RIPA) buffer (Thermo Scientific, Rockford, IL) added with protease inhibitor cocktail (Sigma-Aldrich). Then, protein was then separated on SDS-PAGE gel (8%) and transferred to PVDF membrane (Millipore,
Billerica, MA). PVDF membrane was blocked with 5% non-fat milk for 2 hr at room temperature and incubated with primary antibodies (anti-CDK14, 1:1000, Abcam, Cambridge, MA) at 4°C overnight. Next, PVDF membrane was incubated with horseradish peroxidase (HRP) secondary antibody for 1 hr at room temperature. Finally, the protein expression was detected using the enhanced chemiluminescence (ECL) substrate kit (Amersham Biosciences, Inc.) using chemiluminescence detection system.
| Luciferase reporter assay
The SNHG15 according to the previous description Liu, Li et al., 2017) . After the injection, tumor volume was measured by a single individual with a digital caliper every 3 days were calculated using the formula 0.5× length × width × width. After the mice were sacrificed, the tumors were extracted and weighted. All the animal experimental procedures were approved by the Animal Experimental Ethics Committee of Jinshan Hospital affiliated to Fudan University.
| Statistical analysis
Data were presented as mean ± standard deviation (SD). All results were analyzed with GraphPad Prism 6 using student's t-tests or one-way ANOVA. p < 0.05 was considered to indicate statistical significance. (Figures 2d and 2e) . In summary, our results showed that lncRNA SNHG15 silencing suppressed the proliferation of NSCLC cells in vitro.
3.3 | LncRNA SNHG15 silencing induced cycle arrest at G0/G1 phase and suppressed the apoptosis of NSCLC cells
To further explore the role of SNHG15 silencing on NSCLC cells phenotype, flow cytometry, and Western blot analysis were performed. Flow cytometry showed that SNHG15 silencing accelerated the apoptosis of A549 and H460 cells compared with empty control transfected cells (Figures 3a and 3b) . Besides, flow cytometry cycle analysis revealed that SNHG15 silencing induced the cycle arrest at G0/G1 phase compared with empty control transfected cells (Figures 3c and 3d) . Western blot showed that SNHG15 silencing decreased the CDK14 protein expression in A549 and H460 cells (Figures 3e and 3f ). In summary, our results showed that SNHG15 silencing induced the cycle arrest at G0/G1 phase and suppressed the apoptosis of NSCLC cells, besides, SNHG15 silencing also decreased the CDK14 protein. showed that CDK14 protein expression was decreased in SNHG15
silencing group compared with control group (Figures 4d and 4e) .
Overall, xenograft assay in vivo showed that SNHG15 silencing inhibited the tumor growth of NSCLC cells, and down-regulated the CDK14 protein expression. 
| DISCUSSION
Emerging evidence have shown that lncRNAs function as oncogenic or suppressor genes in multiple cancers, involving in transcription and post-transcription regulation (Guo, Ma et al., 2017; He et al., 2017) . In present study, our team performed series of experiments to investigate the biological role of lncRNA SNHG15 on non-small-cell lung cancer (NSCLC) tumorigenesis.
The tumorigenesis of NSCLC is a complex pathophysiological processes and numerous factors participate in the pathology Zhang, Wu et al., 2017) . Long non-coding RNAs On the other hand, we found that SNHG15 silencing induced the cycle arrest at G0/G1 phase and suppressed the apoptosis of NSCLC cells, besides, decreased the CDK14 protein. CDK14 acts as one of the important cell cycle-regulation related genes (Li et al., 2014; Pollack et al., 2015) . Meanwhile, SNHG15 regulated the apoptosis and cellcycle of NSCLC cells, suggesting the potential interaction within SNHG15 and cycle modulation. CDK14 protein expression is positively correlated with that of SNHG15. The cycle arrest at G0/G1 phase might induce the cellular process of NSCLC cells and accelerate the apoptosis, casing the blocking of NSCLC progression.
LncRNAs is a type of non-coding RNA without protein coding ability (Song, Sakurai, Shiromoto, & Nishikura, 2016; Wei & Wang, 2015) . Up to now, the main regulation mode of lncRNAs is the miRNA "sponge," indicating the regulation of lncRNAs on functional proteins via sponging miRNAs (Lorenzen & Thum, 2016; Thomson & Dinger, 2016) . In our study, bioinformatics online tools and luciferase assay found that miR-486 targeted the 3′-UTR of lncRNA SNHG15 and SNHG15 function as molecular "sponge" for miR-486. Meanwhile, our results also illustrated that miR-486 targeted CDK14 3′-UTR.
Therefore, we conclude the regulation of SNHG15/miR-486/CDK14
in the NSCLC tumorigenesis. The lncRNA/miRNA/mRNA regulatory pathway has been verified to be an important modulation in NSCLC (Guo, Wang, Ren, & Han, 2018; Jiang et al., 2017; Wang, Chen, Ma, & Li, 2017) . For example, lncRNA MALAT1 is significantly upregulated in five human NSCLC cells and bioinformatic analysis predicts the correlation between miR-124 and MALAT1, and STAT3 is found to be a novel mRNA target of miR-124 (Li, Mei, & Hu, 2017) .
In summary, our results reveal that lncRNA SNHG15 is overexpressed in NSCLC tissue and cell lines, and indicates the poor prognosis. Furthermore, we find that SNHG15 promotes CDK14
protein expression through sponging miR-486 to modulate the NSCLC tumorigenesis, providing a novel insight for NSCLC pathogenesis and potential therapeutic strategy for NSCLC patients.
ACKNOWLEDGMENT
This work was supported by Jinshan Hospital affiliated to Fudan University.
CONFLICTS OF INTEREST
All authors declare no conflicts of interest.
ORCID
Jian-Jun Xu http://orcid.org/0000-0002-6976-5920
Bing Li http://orcid.org/0000-0002-0127-0315
